首页 | 本学科首页   官方微博 | 高级检索  
     

慢性乙型肝炎患者代谢异常对肝纤维化的影响
引用本文:刘大凤,刘亚玲,曾义岚,王林,林军,王丽,胡蓉,兰丽娟,王永,欣怡,胡芯华,包蕾. 慢性乙型肝炎患者代谢异常对肝纤维化的影响[J]. 中华实验和临床感染病杂志(电子版), 2016, 10(5): 541-545. DOI: 10.3877/cma.j.issn.1674-1358.2016.05.006
作者姓名:刘大凤  刘亚玲  曾义岚  王林  林军  王丽  胡蓉  兰丽娟  王永  欣怡  胡芯华  包蕾
作者单位:1. 610061 成都市,成都市公共卫生临床医疗中心内科2. 610061 成都市,成都市公共卫生临床医疗中心副院长办公室3. 610061 成都市,成都市公共卫生临床医疗中心传三4. 610061 成都市,成都市公共卫生临床医疗中心功能室5. 610061 成都市,成都市公共卫生临床医疗中心传二6. 610061 成都市,成都市公共卫生临床医疗中心传一
基金项目:四川省卫生厅课题(No. 070385)
摘    要:
目的探讨慢性乙型肝炎患者代谢异常对肝纤维化的影响。 方法分析110例慢性乙型肝炎患者HOMA-IR、HOMA-β、糖脂代谢异常以及脂肪肝对肝纤维化的影响。 结果HOMA-IR越高,肝脏弹性值(LSM)越高(F = 5.559、P = 0.005),各项肝功能指标、TBil水平亦随HOMA-IR增大而有所升高,但组间差异无统计学意义(P > 0.05)。HOMA-β越差,LSM越高(t =-2.771、P = 0.029),各项肝功能指标、TBil水平亦随HOMA-β降低而有所升高,但组间差异无统计学意义(P > 0.05)。糖代谢状态越差,患者LSM、ALP、GGT水平越高,伴发脂肪肝的比例越高(F = 4.663、10.171、11.331、6.482,P = 0.033、0.002、0.001、0.039),其他肝功能指标、TBil水平亦随糖代谢的恶化而有所升高,但组间差异尚无统计学意义(P > 0.05)。脂代谢异常组较脂代谢正常组及有脂肪肝组较无脂肪肝组肝功能指标、TBil、LSM水平亦有所升高,但组间差异无统计学意义(P > 0.05)。 结论慢性乙型肝炎患者胰岛素抵抗、胰岛β细胞功能减退、糖脂代谢状态的恶化可促进肝纤维化的进程。

关 键 词:肝炎、乙型、慢性  稳态模型胰岛素抵抗指数(HOMA-IR)  稳态模型胰岛β细胞功能指数(HOMA-β)  糖代谢  脂代谢  脂肪肝  肝纤维化  
收稿时间:2015-07-29

Influence of abnormal metabolism on liver fibrosis in patients with chronic hepatitis B
Dafeng Liu,Yaling Liu,Yilan Zeng,Lin Wang,Jun Lin,Li Wang,Rong Hu,Lijuan Lan,Yong Wang,Yi Xin,Xinhua Hu,Lei Bao. Influence of abnormal metabolism on liver fibrosis in patients with chronic hepatitis B[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Version), 2016, 10(5): 541-545. DOI: 10.3877/cma.j.issn.1674-1358.2016.05.006
Authors:Dafeng Liu  Yaling Liu  Yilan Zeng  Lin Wang  Jun Lin  Li Wang  Rong Hu  Lijuan Lan  Yong Wang  Yi Xin  Xinhua Hu  Lei Bao
Abstract:
ObjectiveTo analyze the influence of abnormal metabolism on liver fibrosis in patients with chronic hepatitis B. MethodsThe influence factors on liver fibrosis by abnormal metabolism including HOMA-IR, HOMA-β, abnormal glucose and lipid metabolism, fatty liver disease were analyzed in 110 cases with chronic hepatitis B by the prospective cross-section research. ResultsThe liver stiffness mesurement (LSM) was higher (F = 5.559, P = 0.005) for patients with higher HOMA-IR. The levels of indicators of liver function and TBil also increased with HOMA-IR, but with no significant differences (P > 0.05). With worse HOMA-β, the LSM was higher (t =-2.771, P = 0.029). The levels of indicators of liver function and TBil also increased along with HOMA-β, but with no significant differences (P > 0.05). Along with worse glucose metabolism condition, the LSM, ALP, GGT were higher, the proportion of fatty liver disease was higher (F = 4.663, 10.171, 11.331, 6.482; P = 0.033, 0.002, 0.001, 0.039). The levels of other indicators of liver function and TBil also increased along with worse glucose metabolism condition, but with no significant differences (P > 0.05). The levels of indicators of liver function, TBil and LSM were higher in abnormal lipid group or fatty liver disease group than that in normal lipid group or nonfatty liver disease group, but with no significant differences (P > 0.05). ConclusionsAmong patient with chronic hepatitis B, the insulin resistance, worse island beta cell function, worse glucose and lipid metabolism condition could promote progress of the liver fibrosis.
Keywords:Chronic hepatitis B  Hemeostasis model assement of insulin resistance (HOMA-IR)  Hemeostasis model assement of βcells (HOMA-β)  Glucose metabolism abnormal  Lipid metabolism abnormal  Fatty liver  Liver fibrosis  
本文献已被 CNKI 等数据库收录!
点击此处可从《中华实验和临床感染病杂志(电子版)》浏览原始摘要信息
点击此处可从《中华实验和临床感染病杂志(电子版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号